Medicine Description psycholanz 25/6mg
psycholanz 25/6mg capsules is a medication that combines fluoxetine, a selective serotonin reuptake inhibitor (SSRI), with olanzapine, an atypical antipsychotic. Fluoxetine works by inhibiting the reuptake of serotonin in the brain, thereby increasing serotonin levels in the synaptic cleft, which enhances mood and alleviates depressive symptoms. Olanzapine acts primarily by blocking dopamine and serotonin receptors, which helps stabilize mood and reduce symptoms of mania. The synergy of these two active ingredients addresses both depressive and manic episodes, making psycholanz effective in treating complex mood disorders.
Indications and Uses of psycholanz 25/6mg capsules
- Major depressive disorder
- Bipolar I disorder (acute manic or mixed episodes)
- Depressive episodes associated with bipolar disorder
- Treatment-resistant depression
Side Effects of psycholanz 25/6mg capsules
- Weight gain
- Drowsiness
- Dizziness
- Dry mouth
- Fatigue
- Increased appetite
- Restlessness
- Extrapyramidal symptoms
Storage and Handling
Store psycholanz 25/6mg capsules in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiration date printed on the packaging.
Patient Advice and Precautions
Patients should be informed about the potential for weight gain and monitor their diet accordingly. It is important to avoid abrupt discontinuation of the medication to prevent withdrawal symptoms. Regular follow-up appointments are essential to assess the treatment response and any side effects. Alcohol should be avoided as it may exacerbate drowsiness and other side effects.